Redeye: Tessin - Last quarter with declining loan volumes
Redeye updates its estimates after reviewing Tessin's Q3 report, which came in below our expectations. We believe the Q3 figures are of minor importance, and all eyes are now on the upcoming quarters when the new financing agreement with Pollen Street is expected to start having an impact.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/